<DOC>
	<DOCNO>NCT00267215</DOCNO>
	<brief_summary>This trial assess safety efficacy single dose lumiracoxib 400 mg compare placebo single dose celecoxib 200mg . It also assess safety efficacy 400mg lumiracoxib administer day 7 day compare placebo 200 mg celecoxib twice daily .</brief_summary>
	<brief_title>Efficacy Safety Lumiracoxib</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Lumiracoxib</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<criteria>Inclusion criterion : Osteoarthritis knee Pain intensity baseline least 50mm 100mm visual analog scale Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Lumiracoxib</keyword>
	<keyword>osteoarthritis</keyword>
</DOC>